Skip to content

CING

Cingulate Inc.

NASDAQ · Healthcare · Biotechnology · US

$4.56
−3.39%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
7.50x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
2.83x
Price / sales
—
Price / cash flow
-3.21x

Enterprise value

Enterprise value
$44.2M
EV / sales
—
EV / EBITDA
-1.78x
EV / EBIT
-1.77x
Market cap
$66.3M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026